FiercePharma
  • FierceBiotech
  • FierceBiotechIT
  • FierceBiotechResearch
  • FierceBiomarkers
  • FierceDrugDelivery
  • FierceMedicalDevices
  • FierceVaccines
  • FiercePharma
  • FiercePharmaManufacturing
  • FierceCRO
  • More Fierce Network sites
  • Select another site
  • Advertise
  • Contact

Free Daily Pharma Industry Newsletter Every business day, FiercePharma updates pharmaceutical executives on the latest Pharma industry news and deals. Stay up to date on:

  • Pharma Company News
  • Generic Drug Companies
  • Pharmaceutical Marketing & Sales
  • FDA Regulations & Warnings
  • Phase IV Clinical Trials
  • Contract Manufacturing
Click here to see a sample.

FiercePharma

  • News
  • TOPICS
    • Blockbusters
    • Chutes and Ladders
    • Drug Safety
    • Emerging Markets
    • Financials
    • Generics
    • M&A
    • Patents
    • R&D
    • Regulatory
    • Sales and Marketing
    • Social Media
    • Supply Chain and Manufacturing
  • ANALYSIS
    • Top 10 Pharma CEO Salaries of 2011
      by Damian Garde
    • The Future of Biopharma Manufacturing
      by Tracy Staton
    • More commentary
  • FEATURES
    • Top 10 Best-selling Cancer Drugs in 2011
    • Top 10 Pharma Layoffs of 2011
    • The Top 10 Biotech Deal Terminations of 2011
  • LIBRARY
    • Webinars
    • View All
  • EVENTS
  • JOBS
    • Browse Jobs
    • Post a Job
  • Marketplace
  • Susbscribe
  • Twitter
  • Mobile
Follow US
Tag:

Pegasys

Latest Headlines

Latest Headlines

Australia fines Roche for marketing violations

November 2, 2010
Roche was fined $400,000 for violations of Medicines Australia's code of conduct, including an offer to fund a nurse's salary if a clinic increased use of Pegasys, its hepatitis C drug. Report

Related Tags

  • Hepatitis C
  • Pegintron
  • Vertex Pharmaceuticals
  • Health Canada

Pegasys Press Releases

  • The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys Ph
  • Massive Opportunity Exists in Hepatitis C Market for Recently Approved Protease Inhibitors Victrelis and Incivek According
  • Massive Opportunity Exists in Hepatitis C Market for Recently Approved Protease Inhibitors Victrelis and Incivek According
  • Higher Rebates and Discounts Have Greater Influence on Reimbursement Status for Hepatitis C Therapies Than Superior Clinic
  • Higher Rebates and Discounts Have Greater Influence on Reimbursement Status for Hepatitis C Therapies Than Superior Clinic

Join 86,000+ Insiders SIGN UP FOR OUR NEWSLETTER

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

  • MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
  • Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
  • What's your BIO?June 18-21, 2012 — Boston, MA
MORE EVENTS

Press Releases

  • Chronic Pain Is Relieved by Cell Transplantation in Lab Study
  • Drug-vaccine combo better for breast cancer
  • Marked for destruction: Newly developed compound triggers cancer cell death
  • Orthofix International Completes Divestiture of Sports Medicine Business Unit
  • ConforMIS iTotal CR Knee Replacement System Wins Silver in 2012 Medical Design Excellence Awards
  • More Press Releases

Featured Jobs

  • Entry Level Process Engineer and Lead Process Engineer
    Foster Wheeler Biokinetics - San Francisco, CA
  • Biostatistician (Entry Level) - Permanent Job
    Yoh - Tarrytown, NY, USA
  • Senior Controls Engineer Job
    Celgene Corporation - Phoenix, AZ, US
  • Neurosciences Knowledge Group Lead
    Merck - Rahway, NJ - Kenilworth, NJ - West Point, PA - Boston, MA
  • Director, Marketing IBS Franchise
    Prometheus - San Diego, CA

A publication of FierceMarkets

FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join thousands of pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!

The FierceMarkets Network:

Telecom
  • FierceWireless
  • FierceBroadbandWireless
  • FierceMobileContent
  • FierceDeveloper
  • FierceWireless:Europe
  • FierceTelecom
  • FierceEnterpriseCommunications
  • FierceIPTV
  • FierceOnlineVideo
  • FierceCable
Healthcare
  • FierceHealthcare
  • FiercePracticeManagement
  • FierceHealthIT
  • FierceHealthFinance
  • Hospital Impact
  • FierceEMR
  • FierceMobileHealthcare
  • FierceHealthPayer
Government
  • FierceGovernment
  • FierceGovernmentIT
  • FierceHomelandSecurity
Energy
  • FierceEnergy
  • FierceSmartGrid
Life Sciences
  • FierceBiotech
  • FierceBiotechResearch
  • FiercePharma
  • FierceVaccines
  • FierceBiotechIT
  • FiercePharmaManufacturing
  • FierceMedicalDevices
  • FierceDrugDelivery
  • FierceBiomarkers
  • FierceCRO
Enterprise IT
  • FierceCIO
  • FierceCIO:TechWatch
  • FierceMobileIT
  • FierceContentManagement
Finance
  • FierceFinance
  • FierceComplianceIT
  • FierceFinanceIT
  • Home
  • Subscribe
  • Advertise
  • Mobile Edition
  • RSS
  • Privacy
  • Editors
© 2012 FierceMarkets. All rights reserved.